Improvement of microcirculatory impairment in patients with predialysis chronic kidney disease after AST-120 administration
Abstract Background Endothelial dysfunction starts at an earlier stage in patients with chronic kidney disease (CKD), and induces macro- and microcirculatory impairments. We evaluated whether uremic toxin-lowering therapy could improve endothelial function in patients with CKD. Methods We performed...
Main Authors: | Takayasu Ohtake, Yasuhiro Mochida, Kunihiro Ishioka, Hidekazu Moriya, Sumi Hidaka, Masahiro Hirata, Hirokazu Yamada, Hiromichi Kumagai, Shuzo Kobayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-020-00276-x |
Similar Items
-
A Metabolomic Approach to Clarifying the Effect of AST-120 on 5/6 Nephrectomized Rats by Capillary Electrophoresis with Mass Spectrometry (CE-MS)
by: Takaaki Abe, et al.
Published: (2012-11-01) -
Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes
by: Yasuhiko Tomino, et al.
Published: (2018-06-01) -
Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients
by: Mayumi Asai, et al.
Published: (2019-01-01) -
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
by: Ran‐hui Cha, et al.
Published: (2022-02-01) -
Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease
by: Nagata D, et al.
Published: (2020-12-01)